At Argentina’s leading agricultural and livestock exhibition, Biogénesis Bagó reaffirmed its position as a global biotechnology company dedicated to animal health, productivity, and well-being. In recent years, the company has deepened its international expansion through new investments, stronger production capabilities, strategic partnerships, and the adoption of technologies designed to address the current and future health challenges facing the livestock and veterinary sectors.
During the 138th Palermo Rural Exhibition in Buenos Aires, the company showcased a comprehensive offering that combines animal health, diagnostics, biotechnology, and digital tools to support producers and veterinarians in addressing today’s livestock production challenges. In this context, it announced a strategic agreement with TECPAR to continue bringing technological innovation to the sector, strengthening an offering aimed at improving production efficiency, traceability, and decision-making in the field.
Today, the company operates eight manufacturing facilities, maintains a commercial presence in multiple markets, and employs more than 1,300 people worldwide, consolidating an expansion strategy built on investment, innovation, and technology transfer. This growth has enabled Biogénesis Bagó to establish itself as one of the world’s leading animal health companies while broadening its reach across Latin America, Asia, Europe, Africa, and the Middle East.
In recent years, the company has also sustained growth above the market average, driven by new investments, strategic acquisitions, scientific development, and a strong commitment to innovation. As Sebastián Perretta, the company’s Executive Business Director, emphasized, “investment always prevails over speculation”—a vision that continues to guide the expansion of its production capabilities, research and development activities, and the pursuit of new opportunities for international growth.
Biogénesis Bagó’s global expansion is also reflected in the trust that countries and institutions place in its expertise in preventing and controlling diseases with significant health and economic impact. Recent developments include its participation in strategic foot-and-mouth disease programs, including the safeguarding and management of antigen banks designed to strengthen response capabilities in the event of health emergencies.
In addition to its solutions for livestock, Biogénesis Bagó presented offerings focused on the care and well-being of companion animals, a strategic segment for the company. Through products, services, and awareness initiatives promoting prevention and responsible pet ownership, the company continues to broaden its contribution to animal health through a comprehensive approach that addresses the needs of veterinarians, pet owners, and communities.
With a track record built on science, innovation, and sustained investment, Biogénesis Bagó continues to consolidate its international presence and reaffirm its purpose of contributing to the development of more efficient, sustainable, and secure production systems, bringing knowledge and solutions from Argentina to the world.